Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
06-08 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
06-08 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
04 Jun 2025
// FINANCIALTIMES
12 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/12/3079505/0/en/MoonLake-Immunotherapeutics-Reports-First-Quarter-2025-Financial-Results-and-Provides-a-Business-Update.html
25 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/25/3068623/0/en/MoonLake-Immunotherapeutics-to-host-a-Capital-Markets-Day-on-Tuesday-April-29.html
26 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/26/3032747/0/en/MoonLake-Immunotherapeutics-Reports-Full-Year-2024-Financial-Results-and-Provides-a-Business-Update.html
08 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/08/3006081/0/en/MoonLake-initiates-three-new-clinical-trials-and-further-expands-the-portfolio-of-indications-for-the-Nanobody-sonelokimab.html
13 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/13/2980229/0/en/MoonLake-Immunotherapeutics-starts-Phase-3-IZAR-program-of-the-Nanobody-sonelokimab-in-patients-with-active-psoriatic-arthritis.html
ABOUT THIS PAGE